Chia Yeh-To, MD
Procedural Dermatology · Fresno, CANPI 1528076742
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,202 of the $7,248 with a category attached, or 71.8%. 17 manufacturers reported payments, led by Merz North America, Inc. at 47.2% of the total. Reporting peaked in 2023 at $3,033 and has fallen 75.3% since, to $749 in 2025.
Across 168 payments — averaging $43.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$3K
- AbbVie$2K
- Galderma Laboratories, L.p.$787
- Revance Therapeutics, Inc.$375
- Organogenesis Inc.$240
- Janssen Scientific Affairs, LLC$121
- plus $526 from 11 others
What the payments were for
- Speaking & faculty fees$1021%
- Travel & lodging$1,94427%
- Food & beverage$5,20272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 32 | $3,424 |
| AbbVie(2 entities) | 92 | $1,774 |
| Galderma Laboratories, L.p. | 15 | $787 |
| Revance Therapeutics, Inc. | 10 | $375 |
| Organogenesis Inc. | 5 | $240 |
| Janssen Scientific Affairs, LLC | 1 | $121 |
| EPI Health, LLC | 1 | $102 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $83 |
| Pfizer | 2 | $73 |
| E.r. Squibb & Sons, L.L.C. | 1 | $60 |
| Boehringer Ingelheim | 1 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| DUSA Pharmaceuticals, Inc. | 1 | $21 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $19 |
| Genentech USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,248 in reported general payments places this provider in the 65th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 82 | $5,805 |
| Metronidazole | 41 | $2,632 |
| Ketoconazole | 133 | $1,885 |
| Fluocinonide | 21 | $984 |
| Doxycycline Hyclate | 44 | $816 |
| Clobetasol Propionate | 25 | $483 |
| Triamcinolone Acetonide | 54 | $449 |
| Clindamycin Phosphate | 12 | $331 |
| Doxycycline Monohydrate | 17 | $291 |
| ValacyclovirValacyclovir Hcl | 26 | $270 |
| Nystatin | 11 | $252 |
| Hydrocortisone | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Fresno
- Sam Khalifianla Mesa$3.5M
- Sabrina FabiSan Diego$3.1M
- Natasha MesinkovskaMission Viejo$499K
- Jeanette BlackLos Angeles$492K
- Mitchel GoldmanSan Diego$425K
- Rebecca FitzgeraldLos Angeles$230K
- Suzanne KilmerSacramento$220K
- Zakia RahmanStanford$181K
- Hrak JalianSanta Monica$160K
- Amelia HausauerCampbell$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.